The U.S. Chamber submitted comments to the European Commission as it considers revisions and updates to its General Pharmaceuticals Legislation, which is Europe’s attempt to foster innovation, improve the resiliency of the healthcare sector in Europe, bolster supply chain security, and ensure access to innovative medicines across the EU. We encouraged the EU to do a better job of rewarding and prioritizing innovation, guarantee strong IP protections for manufacturers, and preserve open and integrated global supply chains rather than attempting to cut Europe off from the global economy in healthcare. We also focused on the importance of digital health and transatlantic coordination, including for research and pandemic response and recovery.
Recommended
- International
The Private Sector's Crucial Role in the Americas Partnership
The Partnership intends to improve regional competitiveness and address the hemisphere's most pressing economic issues.
By Tatiana Niang
- International
Driving Digital Transformation with Côte d'Ivoire
By Dr. Guevera Yao - International
European Parliament Elections: Impacts on U.S. Business
By Marjorie Chorlins
View this online